197 related articles for article (PubMed ID: 2105838)
1. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
Kyprianou N; Isaacs JT
Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
[TBL] [Abstract][Full Text] [Related]
2. Genetic instability and the acquisition of metastatic ability by rat mammary cancer cells following v-H-ras oncogene transfection.
Ichikawa T; Kyprianou N; Isaacs JT
Cancer Res; 1990 Oct; 50(19):6349-57. PubMed ID: 2119253
[TBL] [Abstract][Full Text] [Related]
3. Metastatic potential of SP1 mouse mammary adenocarcinoma cells is differentially induced by activated and normal forms of c-H-ras.
Waghorne C; Kerbel RS; Breitman ML
Oncogene; 1987 May; 1(2):149-55. PubMed ID: 3325879
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between intercellular junctional communication, p21rasEJ expression, and spontaneous metastatic properties of rat mammary cells after transfection with c-H-rasEJ or neo genes.
Nicolson GL; Gallick GE; Dulski KM; Spohn WH; Lembo TM; Tainsky MA
Oncogene; 1990 May; 5(5):747-53. PubMed ID: 2189108
[TBL] [Abstract][Full Text] [Related]
5. H-ras expression, genetic instability, and acquisition of metastatic ability by rat prostatic cancer cells following v-H-ras oncogene transfection.
Ichikawa T; Schalken JA; Ichikawa Y; Steinberg GD; Isaacs JT
Prostate; 1991; 18(2):163-72. PubMed ID: 2006121
[TBL] [Abstract][Full Text] [Related]
6. Transfection of activated c-H-rasEJ/pSV2neo or pSV2neo genes into rat mammary cells: rapid stimulation of clonal diversification of spontaneous metastatic and cell-surface properties.
Nicolson GL; Gallick GE; Spohn WH; Lembo TM; Tainsky MA
Oncogene; 1992 Jun; 7(6):1127-35. PubMed ID: 1594244
[TBL] [Abstract][Full Text] [Related]
7. Metastatic potential of cloned murine melanoma cells transfected with activated c-Ha-ras.
Price JE; Aukerman SL; Ananthaswamy HN; McIntyre BW; Schackert G; Schackert HK; Fidler IJ
Cancer Res; 1989 Aug; 49(15):4274-81. PubMed ID: 2663141
[TBL] [Abstract][Full Text] [Related]
8. Genetic factors and suppression of metastatic ability of v-Ha-ras-transfected rat mammary cancer cells.
Ichikawa T; Ichikawa Y; Isaacs JT
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1607-10. PubMed ID: 1542651
[TBL] [Abstract][Full Text] [Related]
9. Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harvey-ras oncogene.
Partin AW; Isaacs JT; Treiger B; Coffey DS
Cancer Res; 1988 Nov; 48(21):6050-3. PubMed ID: 3048653
[TBL] [Abstract][Full Text] [Related]
10. Induction of metastatic ability in a stably diploid benign rat mammary epithelial cell line by transfection with DNA from human malignant breast carcinoma cell lines.
Davies BR; Barraclough R; Rudland PS
Cancer Res; 1994 May; 54(10):2785-93. PubMed ID: 8168111
[TBL] [Abstract][Full Text] [Related]
11. Transfected neu oncogene induces human prostate cancer metastasis.
Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
[TBL] [Abstract][Full Text] [Related]
12. Expression of a transfected v-Harvey-ras oncogene in a Dunning rat prostate adenocarcinoma and the development of high metastatic ability.
Treiger B; Isaacs J
J Urol; 1988 Dec; 140(6):1580-6. PubMed ID: 3057238
[TBL] [Abstract][Full Text] [Related]
13. Transfection of activated Ha-ras protooncogenes causes mouse mammary hyperplasia.
Miyamoto S; Guzman RC; Shiurba RA; Firestone GL; Nandi S
Cancer Res; 1990 Sep; 50(18):6010-4. PubMed ID: 2203525
[TBL] [Abstract][Full Text] [Related]
14. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
Alon Y; Hammerling GJ; Segal S; Bar-Eli M
Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
[TBL] [Abstract][Full Text] [Related]
15. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
Hofmann M; Rudy W; Günthert U; Zimmer SG; Zawadzki V; Zöller M; Lichtner RB; Herrlich P; Ponta H
Cancer Res; 1993 Apr; 53(7):1516-21. PubMed ID: 8453616
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
17. No acquisition of metastatic capacity of R1H rhabdomyosarcoma upon transfection with c-Ha-ras oncogene.
Baisch H; Collard J; Zywietz F; Jung H
Invasion Metastasis; 1990; 10(4):193-207. PubMed ID: 2192992
[TBL] [Abstract][Full Text] [Related]
18. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
Oates AJ; Barraclough R; Rudland PS
Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
[TBL] [Abstract][Full Text] [Related]
19. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
20. Genetic factors and metastatic potential of prostatic cancer.
Ichikawa T; Ichikawa Y; Isaacs JT
Cancer Surv; 1991; 11():35-42. PubMed ID: 1841756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
